NIDA - Research Monographs - Monograph 147: Discovery of Novel Opioid Medications

[Finished Printing? - Click Here to Return to Normal View]

	NIDA Home > Publications > Research Monographs >
	Discovery of Novel Opioid Medications

NIDA Research Monograph, Number 147 [Printed in 1995]

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph147.pdf - Discovery of Novel Opioid Medications (2.1 MB)

Table of Contents

Introduction-----v
Rao S. Rapaka and Heinz Sorer

Targeting Drugs to the Brain by Sequential Metabolism-----1
Nicholas Bodor

Action of Opioid Drugs on the Brain-Reward System-----33
Conan Kornetsky

Drugs That Modify Opioid Tolerance, Physical Dependence, and Abstinence Symptoms: Preclinical and Clinical Studies-----53
Hemendra N. Bhargava

Future Directions in the Pharmacological Management of Hyperalgesic and Allodynic Pain States: The NMDA Receptor-----84
Tony L. Yaksh, Sandra R. Chaplan, and Annika B. Malmberg

Dual Inhibitors of Enkephalin-Degrading Enzymes (Neutral Endopeptidase 24.11 and Aminopeptidase N) as Potential New Medications in the Management of Pain and Opioid Addiction-----104
Bernard P. Rogues and Florence Noble

Enhanced N-Methyl-D-Aspartate (NMDA)-Induced Activity Following Morphine: Sensitivity to Sigma and PCP Ligands-----146
Alice A. Larson, Rustam Yu. Yukhananov, and Julie S. Kreeger

Dynorphin A: A Rectifying Peptide-----161
Nancy M. Lee

Inhibitors of Nitric Oxide Synthase and the Opioid Withdrawal Syndrome-----170
Edythe D. London, Alane S. Kimes, and D. Bruce Vaupel

Nitric Oxide and Opioid Tolerance-----182
Gavril W. Pasternak

Methoclocinnamox: A µ Partial Agonist With Pharmacotherapeutic Potential for Heroin Abuse-----195
James H. Woods, John W. Lewis, Gail Winger, Eduardo Butelman, Jillian Broadbear, and Gerald Zernig

ACEA-1011, a Novel NMDA Receptor/Glycine Site Antagonist, Produces Antinociception but Not Tolerance in the Formalin Test in Mice-----220
Kabirullah Lutfy, John F. W. Keana, and Eckard Weber

Etorphine Elicits Unique Inhibitory-Agonist and Excitatory-Antagonist Actions at Opioid Receptors on Sensory Neurons: New Rationale for Improved Clinical Analgesia and Treatment of Opiate Addiction-----234
Stanley M. Crain and Ke-Fei Shen

The Association of Neuropathic Pain, Morphine Tolerance and Dependence, and the Translocation of Protein Kinase C-----269
David J. Mayer, Jianren Mao, and Donald D. Price

The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008.